Info about some of Our Current Studies
A5402 – This study will compare two medicines that are used to treat depression in people living with HIV. Researchers will look at how these medicines affect symptoms of depression, memory, thinking, and daily functioning over time.
To learn more about this study, email the research nurse: Morgan Lima, RN (morgan.c.shearer@vumc.org).
A5424 – This study will look at the safety of hormone therapy and how it affects hot flashes, sleep, mood, and daily life in menopausal people who are living with HIV. Women living with HIV who are experiencing moderate to severe hot flashes or night sweats may be eligible.
To learn more about this study, email the research nurse: Tracey Watkins, LPN (tracey.d.watkins@vumc.org).
GL1DER – GL1DER – This study will look at whether a GLP-1 medication affects alcohol use, smoking, and heart health in people living with HIV. People living with HIV who drink alcohol regularly may be eligible.
To learn more about this study, email the research coordinator: Rachel Jones, (rachel.l.jones3@vumc.org).
DAYBREAK – This study will compare two long-acting HIV treatment approaches in adults living with HIV whose virus is currently controlled. Researchers will monitor safety, tolerability, and how participants experience each treatment over time.
To learn more about this study, email the research nurse: Morgan Lima, RN (morgan.c.shearer@vumc.org).
PROPEL – This study will learn how people choose and use different HIV prevention options in real-world healthcare settings. People interested in HIV prevention services, including long-acting prevention medicines, may be eligible.
To learn more about this study, email the research nurse: Kelly Henderson, LPN (kelly.n.henderson@vumc.org).
